Evidence map›Paper›PMID 40968357›Full record

ArticleBMC pregnancy and childbirth2025

Inflammatory and fibrosis indices (UA/Alb, Fib/UA, UA/Cr, Cr/BW, AST/PLT, AST/ALT, FIB-4, and FIB-5) as predictors of preeclampsia-associated systemic dysfunction.

Ruken Dayanan, Burak Bayraktar, Ahmet Arif Filiz, Merve Ayas Ozkan, Dilara Duygulu Bulan, Gulsan Karabay, Zeynep Seyhanli, Deniz Ozturk Atan, Zehra Vural Yilmaz

Abstract read
In one paragraph

Article in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ruken DayananDepartment of Perinatology, Ankara Etlik City Hospital, Ankara, 06170, Turkey. rukendayanan@gmail.com.ORCID http://orcid.org/0000-0002-8192-8841
Burak BayraktarDepartment of Perinatology, Ankara Etlik City Hospital, Ankara, 06170, Turkey. drburakbayraktar@gmail.com.ORCID http://orcid.org/0000-0001-6233-4207
Ahmet Arif FilizDepartment of Perinatology, Ankara Etlik City Hospital, Ankara, 06170, Turkey.ORCID http://orcid.org/0000-0002-6137-0270
Merve Ayas OzkanDepartment of Perinatology, Ankara Etlik City Hospital, Ankara, 06170, Turkey.ORCID http://orcid.org/0000-0002-2437-9719
Dilara Duygulu BulanDepartment of Perinatology, Ankara Etlik City Hospital, Ankara, 06170, Turkey.ORCID http://orcid.org/0000-0001-9983-2306
Gulsan KarabayDepartment of Perinatology, Ankara Etlik City Hospital, Ankara, 06170, Turkey.ORCID http://orcid.org/0000-0003-2567-2850
Zeynep SeyhanliDepartment of Perinatology, Ankara Etlik City Hospital, Ankara, 06170, Turkey.ORCID http://orcid.org/0000-0003-3924-3723
Deniz Ozturk AtanDepartment of Obstetrics and Gynecology, Ankara Etlik City Hospital, Ankara, Turkey.ORCID http://orcid.org/0000-0002-6056-9755
Zehra Vural YilmazDepartment of Perinatology, Ankara Etlik City Hospital, Ankara, 06170, Turkey.ORCID http://orcid.org/0000-0002-8719-1879

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to evaluate the clinical and prognostic value of various inflammatory and metabolic indices in identifying of early-onset (EO-PE) and late-onset preeclampsia (LO-PE) and in predicting composite adverse maternal outcomes (CAMO), composite adverse perinatal outcomes (CANO), and disease severity.

methodsThis retrospective cohort study included 625 singleton pregnant women followed at a tertiary center between January 1, 2023, and January 1, 2025. The study group comprised 320 preeclamptic women (170 EO-PE < 34 weeks, 150 LO-PE ≥ 34 weeks), while 305 gestational age-matched healthy pregnancies served as controls (155 early controls, 150 late controls). Preeclampsia cases were further classified into 155 severe and 165 mild cases. The indices analyzed included uric acid/albumin ratio (UA/Alb), fibrinogen/uric acid ratio (Fib/UA), uric acid/creatinine ratio (UA/Cr), creatinine/body weight ratio (Cr/BW), AST/platelet ratio (AST/PLT), AST/ALT ratio, and fibrosis indices (FIB-4 and FIB-5). Composite adverse maternal outcomes (CAMO) include the presence of at least one of the following maternal outcomes: thrombocytopenia, renal dysfunction, hepatic dysfunction, HELLP syndrome (hemolysis, elevated liver enzymes, low platelet count), disseminated intravascular coagulation (DIC), pulmonary edema, eclampsia, and admission to the maternal intensive care unit (ICU). Composite adverse neonatal outcomes (CANO) include the presence of at least one of the following adverse outcomes: transient tachypnea of the newborn, respiratory distress syndrome, need for continuous positive airway pressure, need for mechanical ventilation, need for phototherapy, neonatal hypoglycemia, intraventricular hemorrhage, necrotizing enterocolitis, neonatal sepsis, 5th minute APGAR score < 7, neonatal intensive care unit (NICU) admission, placental abruption, and preterm birth.

resultsThe UA/Alb ratio and Fib/UA ratio were the most strongly associated with EO-PE and LO-PE, with high discriminative accuracy (AUC = 0.831 and 0.888, respectively). These indices also showed strong associations with CAMO, CANO, and disease severity. In contrast, the AST/ALT ratio was not significantly associated with PE discrimination, severity, CAMO, or CANO. The AST/PLT ratio and FIB-4 were significantly associated with both EO-PE and LO-PE, while FIB-5 was only associated with EO-PE. Both FIB-4 and FIB-5 were significantly linked to CAMO and CANO in EO-PE cases, but not in LO-PE. Both indices were also associated with severe preeclampsia. Although the Cr/BW ratio was associated with disease severity, it showed limited value in distinguishing EO-PE or LO-PE from the control group and was only related to CAMO and CANO in EO-PE.

conclusionOur study identified UA/Alb and Fib/UA ratios as the most informative indices for classifying EO-PE and LO-PE, assessing CAMO and CANO risk, and evaluating disease severity. The high AUC values support their potential clinical applicability. Conversely, the AST/ALT ratio was not significantly associated with preeclampsia diagnosis, disease severity, differentiation of CAMO or CANO.

Indexed as

InflammationPre-EclampsiaAdultBiomarkersCase-Control StudiesFemaleFibrosisHumansInfant, NewbornMaternal AgePredictive Value of TestsPregnancyPrognosisSeverity of Illness IndexYoung AdultBiomarkersAST/ALT ratioAST/PLT ratioCreatinine/body weight ratioFIB 4FIB 5Fibrinogen/uric acid ratioPreeclampsiaUric acid/albumin ratio

Identifiers

PMID40968357
PMCPMC12447607

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.